Astellas
Astellas appoints comms head from Baxter
September 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris
Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …
FDA approves new indication for Xtandi
September 11, 2014Sales and Marketing Astellas, FDA, Medivation, Xtandi, Zytiga, prostate
The FDA has approved Astellas Pharma and Medivation’s prostate cancer drug Xtandi (enzalutamide) for use in patients who have not …
Cancer Research UK and Astellas announce partnership
August 8, 2014Medical Communications, Research and Development, Sales and Marketing Astellas, CRUK, Canncer, Pancreatic cancer
Cancer Research UK and its commercial arm, Cancer Research Technology (CRT) have announced they are joining forces with Astellas in …
Astellas Pharma announces new senior hires
August 7, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas
Astellas Pharma EMEA, the European division of Astellas Pharma, has appointed Simon Dew to the position of chief strategy officer …
NICE ‘yes’ for cancer drugs
July 23, 2014Sales and Marketing Astellas, BMS, Cancer, NICE, Xtandi, Yervoy
Two big-name oncology brands, Bristol-Myers Squibb’s Yervoy and Astellas Pharma’s Xtandi, have been given the nod by drug costs watchdog …
Astellas names Americas head
July 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Tatjana Dragovic, americas
Astellas has appointed Tatjana Dragovic as its VP and regional compliance officer for the firm’s Americas region. In this role …
NICE recommends Xtandi
May 9, 2014Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate
NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …
Lundbeck teams up with Lieber Institute
April 3, 2014Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …
Aveo and Astellas part ways
February 17, 2014Sales and Marketing Astellas, Aveo, Boehringer, EMA, tivozanib
Aveo Oncology and Astellas Pharma are to abandon their three-year old collaboration and licence agreement for investigational tyrosine kinase inhibitor …
Sir Michael Parkinson criticises NICE
February 4, 2014Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate
TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …
NICE looks at Xtandi again
January 28, 2014Sales and Marketing Astellas, NHS, NICE, Xtandi
NICE has announced it is to consult again on its decision to recommend Astellas Pharma’s prostate cancer drug Xtandi after …
Astellas seeks Xtandi extension
December 5, 2013Sales and Marketing Astellas, Cancer, EU, FDA, US, Xtandi
Astellas Pharma and development partner Medivation are seeking to extend the reach of oncology brand Xtandi by conducting a trial …
Astellas hires senior VP from rival Takeda
August 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology
Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …
Astellas in $500m deal with Cytokinetics
June 27, 2013Sales and Marketing Astellas, cytokinetics
Astellas Pharma could pay out $40 million over the next two years to US firm Cytokinetics as part of a …
Xtandi gets EU approval
June 26, 2013Sales and Marketing Astellas, FDA, Xtandi
Astellas Pharma’s Xtandi has been approved in the European Union for the treatment of adult men with advanced prostate cancer, …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
